Abstract

Abstract Freshly thawed mesenchymal stromal cells (MSCs) transiently display altered cell physiology and a recent report by Chinnadurai et al. [Stem Cells 2016;34:2429–2442] demonstrated that thawed allogeneic MSCs are also susceptible to T-cell mediated lysis in vitro and that this effect can be mitigated by activating MSCs with IFN-γ prior to freeze and thaw. In the letter to the editor by Ankrum et al., “Function of Cryopreserved MSCs with and without IFN-γ pre-licensing is Context Dependent,” the author provide data that IFN-γ pretreatment of human MSCs before cryobanking fails to enhance their potency post thaw in a mouse model of retinal disease. Considering that the experimental set up involves the use of human MSCs in mice with normal immune systems, we propose that IFN-γ MSC activation enhances the immune incompatibility of xenogenic human cells in a manner which may confound the predictive value for human translational use.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.